CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 8th, 2012

Michael Ezekowitz Joining Cardiovascular Research Foundation to Establish AFib Research Center

Michael Ezekowitz is joining the Cardiovascular Research Foundation (CRF) in New York City to start a new center for atrial fibrillation research. Ezekowitz, a cardiologist at the Lankenau Institute for Medical Research in Philadelphia, had been a professor and vice president for clinical research at Lankenau. Recently, Ezekowitz was a co-principal investigator of the RE-LY trial of dabigatran versus warfarin for stroke prevention in AF patients. Ezekowitz went to medical school in South Africa, received a D. Phil from Imperial College at London University, and completed his cardiology fellowship at Johns Hopkins.

Ezekowitz’s appointment represents a new area of interest for CRF, which has traditionally focused on procedures and devices associated with interventional cardiology. The CRF’s Gregg Stone said:

 

We’ve always had an intense interest in the intersection between pharmacotherapy and interventional cardiology. Atrial fibrillation management has emerged as an entity that may be treated with pharmacology, intervention (left atrial appendage closure), EP ablation and/or surgery – so this area is a natural for CRF. Mike is one of the world’s foremost authorities on the management of patients with atrial fibrillation, having led or been involved with many of the seminal studies in Afib over his distinguished career. We are very pleased that he has brought his prodigious talents to CRF.

Categories: Electrophysiology, General
Tags: ,


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.